Tuesday Health was founded on a simple but powerful belief: that people with serious illness deserve care that is compassionate, personalized, and aligned with their values. To meet these needs, we established a value-based palliative care provider group to improve outcomes for our most vulnerable patients.
Tuesday Health combines expert clinical teams with innovative digital tools to support individuals and their caregivers in-person and across care settings. Our solution includes symptom management, advance care planning, and emotional support, delivered through in-person visits, telehealth, and 24/7 access to care. Tuesday Health’s care model expands reach and continuity, helping patients avoid unnecessary hospitalizations and focus on what matters most to them. Our mission is to empower individuals and their loved ones throughout their serious illness journey.
In every decision and action we take, we put our members first.
This is our commitment to our members, our clients, and our colleagues.
We believe in the power of constructive discourse to drive growth and innovation.
By valuing diversity and encouraging vulnerability, we create a safe and inclusive space where authenticity is expected and celebrated.
We honor every commitment we make.
Dr. Areej El-Jawahri is a medical oncologist and an internationally renowned clinical researcher focused on developing, testing, and implementing palliative and supportive care interventions for patients with serious illness. She serves as Director of Digital Health at the Massachusetts General Hospital, Director of Transplant Survivorship, and the Associate Director of the MGH Cancer Outcomes Research and Education Program. Dr. El-Jawahri brings her expertise in palliative care and implementation research to Tuesday Health’s innovative, evidence-based model of supportive care.
Dr. Jackson, a general internist, is the Chief of the Palliative Care at Massachusetts General Hospital. She received her palliative care fellowship training at the Pain & Palliative Care Service at the Dana-Farber Cancer Institute and the Brigham and Women’s Hospital. Her research and educational interests include improving physician’s care of patients with life-threatening illness.
Dr. Theresa Soriano is a board-certified general internist, palliative medicine physician and Adjunct Professor at the Icahn School of Medicine at Mount Sinai. She is nationally recognized in the field of home and community-based primary and palliative care clinical practice, quality, and leadership. She has held direct provider, academic, clinical-operational and executive roles in home-based models, hospital operations, care management, and population health at academic systems as well as start-up and early-stage companies including Mount Sinai Health System, Cityblock, Prospero, Landmark and Optum. As the founder of TAS Health Advisory, she helps early stage and established organizations develop, plan and implement clinical strategies and initiatives. Her work with Tuesday Health enables Dr. Soriano to support Tuesday’s leadership to expand innovative and high-quality supportive care to more patients with serious illness.
Dr. Strand is currently Chair, Enterprise Center for Palliative Medicine and Assistant Professor of Medicine, Mayo Clinic College of Medicine and Sciences.
He sees hospitalized patients with complex symptom needs on the inpatient palliative care services and works closely with patients and their caregivers to manage complications of serious illness, particularly patients with cancer and advanced heart failure in the outpatient Symptom Management, Pain and Quality of Life Clinic at Mayo Clinic in Rochester.
Dr. Strand’s clinical research interests center around the integration of palliative medicine into the care of patients with cancer and advanced cardiac disease, management of complex cancer-related pain and barriers to cancer pain management. He participates in several active national research protocols and lectures nationally and internationally on these topics.
Dr. Craig D. Blinderman, M.D., M.A., FAAHPM is a national leader in palliative medicine and the Chief of the Supportive Care Service at Memorial Sloan Kettering Cancer Center (MSKCC). He has held pivotal roles as the Director of the Adult Palliative Care Service at Columbia University Irving Medical Center/NewYork-Presbyterian Hospital and the Program Director of the Bi-Campus (Columbia and Cornell) Hospice and Palliative Medicine Fellowship at NewYork-Presbyterian Hospital. From 2006-2010 Dr. Blinderman served as an attending physician on the Palliative Care Service at the Massachusetts General Hospital (MGH) and was the co-founder of the MGH Cancer Pain Clinic. Dr. Blinderman has helped demonstrate the value of early palliative care in cancer care with colleagues at MGH in a landmark study (Temel J, et al. NEJM 2010). Dr. Blinderman also wrote the first evidence-based review for providing comfort care for the dying (Blinderman, Billings, NEJM 2015). In addition, he has been involved in educating students, trainees and fellows on the principles and practice of palliative care. Lastly, he has developed innovative clinical programs supportive care at both Columbia and MSK to increase access and quality of care for patients with cancer and other serious illnesses.
Joseph Shega, MD, is executive vice president and chief medical officer for VITAS Healthcare, the nation’s leading provider of end-of-life care. He is board certified in geriatric and hospice and palliative medicine, and has been caring for, studying, and teaching about geriatric patients and end-of-life care since 1999. He joined VITAS in 2013 as regional medical director, was named senior vice president and national medical director in 2016, and was promoted to chief medical officer in 2018 and to executive vice president in 2021.
